Home›Stock Screener›Dr. Agrawals Eye Hospital›Financial Statements

Dr. Agrawals Eye Hospital Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Dr. Agrawals Eye Hospital (DRAGARWQ) reported revenue ₹471 Cr, net profit ₹70 Cr and EPS ₹147.02, with a net profit margin of 14.9% and ROE of 20.2%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse DRAGARWQ promoter holding to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 14.86% 2026 data
EBITDA Margin 30.79% 2026 data
Operating Margin 31.00% 2026 data
Return on Assets 9.13% 2026 data
Return on Equity 20.23% 2026 data

Balance Sheet Ratios

Current Ratio 0.44 2026 data
Equity Ratio 45.11% 2026 data
Asset Turnover 0.61 2026 data

DRAGARWQ Revenue, Net Profit & EBITDA — Year-on-Year Growth

DRAGARWQ YoY (March 2025 vs March 2026) — revenue +17.2%, net profit +27.3%, EBITDA +16.9%, expenses +16.8%. For live price, earnings ratios and company overview, see DRAGARWQ stock price BSE.

Revenue Growth
+17.2%
Year-over-Year
Net Profit Growth
+27.3%
Year-over-Year
EBITDA Growth
+16.9%
Year-over-Year
Expense Growth
+16.8%
Year-over-Year
Assets Growth
+25.1%
Year-over-Year
Equity Growth
+64.8%
Year-over-Year
Operating Cash Flow Growth
+5.6%
Year-over-Year
Investing Cash Flow Growth
-90.0%
Year-over-Year
Financing Cash Flow Growth
+221.4%
Year-over-Year

DRAGARWQ Income Statement — Revenue, EBITDA & Net Profit

Dr. Agrawals Eye Hospital revenue ₹471 Cr, EBITDA ₹145 Cr, net profit ₹70 Cr, EPS ₹147.02 (2026) — net profit margin 14.9%. Also explore DRAGARWQ price trends to track price trends across different timeframes.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 471 402 324 270 203 141 179 172 156 150 137 118
Expenses 326 279 228 193 144 109 130 141 130 127 120 104
EBITDA 145 124 96 77 59 31 49 31 26 23 17 15
Operating Profit Margin % 31.00% 30.00% 29.00% 28.00% 29.00% 22.00% 26.00% 17.00% 15.00% 14.00% 12.00% 12.00%
Depreciation 46 40 27 20 20 19 21 11 10 9 9 6
Interest 12 13 7 7 6 6 8 3 3 3 4 3
Profit Before Tax 94 71 62 49 32 6 20 17 13 11 -1 5
Tax 23 16 16 13 8 7 6 6 7 4 -1 0
Net Profit 70 55 46 37 24 -1 14 12 7 7 0 6
Earnings Per Share (₹) 147.02 116.28 98.64 78.55 51.28 -3.06 29.11 25.35 14.42 15.61 0.08 12.12

DRAGARWQ Balance Sheet — Assets, Liabilities & Shareholders' Equity

DRAGARWQ total assets ₹767 Cr, total equity ₹346 Cr, total liabilities ₹ Cr (2026) — ROE 20.2%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 767 613 496 390 314 155 141 100 81 72 79 69
Current Assets 137 56 60 47 50 44 30 30 23 20 24 23
Fixed Assets 600 393 316 260 214 96 94 55 36 33 34 27
Capital Work in Progress 197 128 97 62 27 0 0 0 3 1 1 0
Investments 14 13 0 0 0 0 0 0 0 0 0 0
Other Assets 0 80 83 67 73 60 47 45 42 38 44 43
LIABILITIES
Total Liabilities
Current Liabilities 309 317 258 222 183 52 45 19 9 16 19 15
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 346 210 157 113 78 55 56 46 35 29 23 24
Share Capital 5 5 5 5 5 5 5 5 5 5 5 5
Reserves & Surplus 342 205 152 109 74 50 51 41 30 25 19 19

DRAGARWQ Cash Flow Statement — Operating, Investing & Financing

Dr. Agrawals Eye Hospital operating cash flow ₹95 Cr, investing ₹-133 Cr, financing ₹17 Cr, net cash flow ₹-22 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 95 90 70 57 34 39 25 19 20 17 14
Investing Activities -133 -70 -71 -46 -11 -17 -25 -11 -8 -17 -10
Financing Activities 17 -14 0 -4 -8 -20 2 -8 -12 0 -5
Net Cash Flow -22 6 -1 7 15 2 2 -1 0 0 -1